PREAMBLE
Health issues in general, and endocrine related issues in particular, are vital determinants of the prosperity of society. The people of South Asia share many common features and face similar challenges related to endocrine health. These hurdles have been amplified by the rapid socioeconomic and lifestyle changes taking place in the region. Competing priorities and limited resources have prevented the implementation of strategies to meet these obstacles. SAFES wishes to improve endocrine health care delivery in South Asia, using a broad-based, inclusive strategy, based on scientific evidence.
DECLARATION
SAFES, in consultation with each of its associations, has listed, analyzed, and prioritized various endocrine public health issues. Gestational diabetes mellitus (GDM) has been identified as the focus of attention for the term 2015–2017.
RATIONALE
The incidence of GDM is on the rise in all South Asian nations, and may predict the future prevalence of type 2 diabetes mellitus as well. Asians are particularly at increased risk of GDM as found in multi-ethnic studies.[1] Prevalence of GDM in South Asian countries varies substantially according to the screening strategy and diagnostic criteria applied, and ranges from 1% to 20%, with evidence of an increasing trend over recent years.[2] Among the SAFES states, India has a higher age-standardized prevalence of hyperglycemia in pregnancy, with estimates of 27.5% (with IADPSG criteria for GDM). The prevalence in Bangladesh and Sri Lanka has been reported to be around 10%.[3,4] Researchers from Pakistan and Nepal have reported a prevalence of around 1%.[5,6] in low-risk subjects.
GDM is a condition, which is unique in many ways. Affecting two lives at a time, it has an inter-generational impact as well.[7,8] The offspring of mothers with GDM have adverse cardiometabolic profiles and are at increased risk of diabetes and obesity, which further contributes to the epidemic of noncommunicable diseases. GDM lends itself to timely management and to prevention as well. All levels of prevention: Primary, secondary, tertiary, and quaternary, find a suitable playing field in GDM. The management of GDM is predominantly nonpharmacological, but may require the support of medication, like insulin, too.
Our aim should be to improve short and long-term outcomes, for both mother and her offspring. GDM is a perfect example of the need for a life cycle approach, interdisciplinary care, long-term follow-up, and fostering of patient-physician-family interaction. GDM impacts not only the individual or family, but public health as well. There is a need for large-scale prevention and intervention programmes to improve glucose control and maternal health during pregnancy, and sustain them postpartum.[2]
The Dhaka Declaration was released at the 2nd South Asian Federation of Endocrine Societies (SAFES) Summit, held at Dhaka, Bangladesh, from 24 to 26 April, 2015, by Prof Hajera Mahtab, on behalf of SAFES. The Dhaka Declaration will be published simultaneously in national journals and newsletters of the constituent countries of SAFES.
OBJECTIVES
SAFES hereby resolves to:
Promote universal screening for GDM in pregnancy, using nationally and internationally accepted methodology, at least once in each trimester
Facilitate the use of uniform criteria for diagnosis of GDM
Ensure optimal management of GDM, with medical nutrition therapy, lifestyle modification, and conventional/modern insulins, as appropriate
Encourage long-term follow-up of, and necessary medical attention for, women with GDM
Facilitate rational insulin prescription, technique and disposal, and self-monitoring of blood glucose.
ACTIVITIES
To achieve these goals, SAFES will endeavor to:
Establish linkage with national/international professional organizations which work in the field of GDM
Carry out screening programmes for GDM in all South Asian countries
Organize educational activities related to the screening, diagnosis, current medical and obstetric management (including rational use of insulin), and postpartum follow-up of GDM
Explore cost-effective, pragmatic avenues of increasing antenatal and postpartum screening for GDM
Advocate the inclusion of GDM prevention in national health programmes
Educate field health care providers about the diagnosis, treatment, and screening of GDM
Explore avenues for both single center and multicenter studies for research into unique aspects of GDM in South Asian countries.
SAFES will monitor its activities using the following indicators:
Publications from South Asia on GDM
Presentations on GDM at various platforms especially the SAFES Endocrine Summit, and National endocrine society meetings
Number of educational activities organized on GDM
-
Audit of management practices of members of national organizations of SAFES.
- GDM screening practices
- GDM management
- Insulin usage
- Insulin disposal practices
- Self-monitoring of blood glucose practices.
CONCLUSION
The SAFES forum hopes to harness available resources, achieve best possible outcomes in GDM prevention and management and ensure:
Involvement of all stakeholders
Improvement of awareness
Development of necessary action plans
Formulation of policy for implementation of action plans.
Financial support and sponsorship
Nil.
Conflict of interest
There are no conflicts of interest.
REFERENCES
- 1.Mukerji G, Chiu M, Shah BR. Impact of gestational diabetes on the risk of diabetes following pregnancy among Chinese and South Asian women. Diabetologia. 2012;55:2148–53. doi: 10.1007/s00125-012-2549-6. [DOI] [PubMed] [Google Scholar]
- 2.Tutino GE, Tam WH, Yang X, Chan JC, Lao TT, Ma RC. Diabetes and pregnancy: Perspectives from Asia. Diabet Med. 2014;31:302–18. doi: 10.1111/dme.12396. [DOI] [PubMed] [Google Scholar]
- 3.Guariguata L, Linnenkamp U, Beagley J, Whiting DR, Cho NH. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract. 2014;103:176–85. doi: 10.1016/j.diabres.2013.11.003. [DOI] [PubMed] [Google Scholar]
- 4.Jesmin S, Akter S, Akashi H, Al-Mamun A, Rahman MA, Islam MM, et al. Screening for gestational diabetes mellitus and its prevalence in Bangladesh. Diabetes Res Clin Pract. 2014;103:57–62. doi: 10.1016/j.diabres.2013.11.024. [DOI] [PubMed] [Google Scholar]
- 5.Jawa A, Raza F, Qamar K, Jawad A, Akram J. Gestational diabetes mellitus is rare in primigravida Pakistani women. Indian J Endocrinol Metab. 2011;15:191–3. doi: 10.4103/2230-8210.83404. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Shrestha A, Chawla CD. The glucose challenge test for screening of gestational diabetes. Kathmandu Univ Med J (KUMJ) 2011;9:22–5. doi: 10.3126/kumj.v9i2.6282. [DOI] [PubMed] [Google Scholar]
- 7.Sajani TT, Rahman MT, Karim MR. Maternal and fetal outcome of mothers with gestational diabetes mellitus attending BIRDEM Hospital. Mymensingh Med J. 2014;23:290–8. [PubMed] [Google Scholar]
- 8.Sayeed MA, Jahan S, Rahman MM, Chowdhury MH, Khanam PA, Begum T, et al. Prevalance and perinatal outcomes in GDM and non-GDM in a rural pregnancy cohort of Bangladesh. Ibrahim Med J. 2014;7:21–7. [Google Scholar]